Endocrinology, Diabetes & Metabolism Doctors in Fremont, CA Accepting Medicare

5 Endocrinology, Diabetes & Metabolism doctors found. Showing 1 - 5

Dr. Lakshmi Srinivasan, MD Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 3200 Kearney St, Fremont, CA 94538 Phone: 510-490-1222

Yih Chang, M.D. Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 2147 Mowry Ave, Ste D3, Fremont, CA 94538 Phone: 510-648-2087

Dr. Prasad Katta, M.D. Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 2557 Mowry Ave, Suite 12, Fremont, CA 94538 Phone: 510-248-1550    Fax: 510-793-8783

Dr. Edward John Meyer, M.D. Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 2333 Mowry Ave, Ste 300, Fremont, CA 94538 Phone: 530-899-9112    Fax: 530-899-0142

Susan Peng, MD Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 3200 Kearney St, Fremont, CA 94538 Phone: 510-490-1222

News Archive

Ebola research: an interview with Professor Easton, University of Warwick

Ebola virus belongs to a group of viruses that have been known for some time. It was first isolated as a result of an infection in a primate, in a monkey colony, in monkeys that were being used for research in the Philippines.

SGC, Life Technologies to generate first-ever master set of epigenetic recombinant antibodies

Life Technologies Corporation today announced it has signed a collaborative partnership with the Structural Genomics Consortium (SGC), and several groups of leading expert scientists in antibody technology at the Universities of Chicago and Toronto, to generate a first-ever master set of quality epigenetic recombinant antibodies for use in disease-related research.

FDA grants LifeCycle Pharma SPA for LCP-Tacro pivotal Phase 3 study in 'de novo' kidney transplant patients

LifeCycle Pharma A/S today announced receipt of agreement with the U.S. Food and Drug Administration on a Special Protocol Assessment of its pivotal Phase 3 study, Study 3002, for LCP-Tacro in patients, who have just received a kidney transplant.

New MR Solutions maintenance and upgrade service available for Agilent MRI systems

A new maintenance and upgrade service is available for existing Agilent MRI preclinical imaging equipment, by MR Solutions Ltd, based in Guildford, Surrey. Following Agilent's withdrawal from this market, a package of maintenance and upgrade solutions has been developed to ensure that these machines stay abreast of modern technology.

Lions Eye Institute for Transplant & Research to study vision impairment and blindness

Real-time biomedical studies of factors leading to vision impairment are now possible through the world's largest ocular research center at Lions Eye Institute for Transplant & Research.

Read more Medical News

› Verified 6 days ago